It is an object of the present invention to provide a therapeutic agent for effectively preventing or ameliorating diseases caused by dysfunction of NOS. The present invention provides a pharmaceutical composition for preventing and/or treating diseases associated with dysfunction of NOS, comprising as an effective ingredient, a compound of the formula (I): wherein R.sup.1 and R.sup.2 each represents a hydrogen atom or, taken together with each other, represent a single bond, while R.sup.3 represents --CH(OH)CH(OH)CH.sub.3, --CH(OCOCH.sub.3)CH(OCOCH.sub.3)CH.sub- .3, --CH.sub.3, --CH.sub.2OH, or a phenyl group when R.sup.1 and R.sup.2 each represents a hydrogen atom, or --COCH(OH)CH.sub.3 when R.sup.1 and R.sup.2 together represent a single bond, or a pharmaceutically acceptable salt thereof.

 
Web www.patentalert.com

< Six-membered heterocycles useful as serine protease inhibitors

< Aryl-substituted piperazine derivatives

> Pyridazine derivatives and their use as therapeutic agents

> Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof

~ 00232